AGM
ALBO

Alpine Global Management’s Albireo Pharma Inc ALBO Stock Holding History

Alpine Global Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,161
Closed -$309K – 489
2019
Q4 		$309K Buy
+12,161
New +$243K 0.07% 270

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Alpine Global Management's ALBO Position: Q1 2020 in Review

Alpine Global Management sold out of Albireo Pharma Inc (ALBO) in Q1 2020, closing a stake of 12,161 shares — an estimated $309K sold.

Alpine Global Management first reported a position in ALBO in Q4 2019 and held it in 1 quarter. The position peaked at $309K in Q4 2019. 69 funds tracked by Wall St. Rank hold ALBO as of Q1 2020.

  • Alpine Global Management reported no remaining Albireo Pharma Inc position as of Q1 2020 after selling out during the quarter.
  • Alpine Global Management sold 12,161 Albireo Pharma Inc shares in Q1 2020, an estimated $309K.
  • Alpine Global Management first reported a position in Albireo Pharma Inc in Q4 2019 and held it in 1 quarter.
  • Alpine Global Management's Albireo Pharma Inc position peaked at $309K in Q4 2019.
  • 69 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.